| Nau KC, Lewis WD
Multiple myeloma: diagnosis and treatment. [Journal Article]
Am Fam Physician 2008 Oct 1; 78(7):853-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Weigert O, Wittmann G, Gruetzner S, et al.
Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded platelets. [Journal Article]
Thromb Haemost 2008 Oct; 100(4):705-7.
Full Citation | Find Related Articles | | Porter CC, Carver AE, Albano EA
Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2008 Oct 6.
Abstract | Full Citation | Find Related Articles | | Pachera S, Nishio H, Takahashi Y, et al.
Undifferentiated embryonal sarcoma of the liver: case report and literature survey. [Journal Article]
J Hepatobiliary Pancreat Surg 2008; 15(5):536-44.
Abstract | Full Citation | | Rosenkranz V, Wink M
Alkaloids Induce Programmed Cell Death in Bloodstream Forms of Trypanosomes (Trypanosoma b. brucei). [Journal Article]
Molecules 2008; 13(10):2462-73.
Abstract | Full Citation | | Casado P, Prado MA, Zuazua-Villar P, et al.
Microtubule interfering agents and KSP inhibitors induce the phosphorylation of the nuclear protein p54(nrb), an event linked to G2/M arrest. [JOURNAL ARTICLE]
J Proteomics 2008 Sep 14.
Abstract | Full Citation | | Heaney ML, Gardner JR, Karasavvas N, et al.
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Cancer Res 2008 Oct 1; 68(19):8031-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Duan Z, Choy E, Jimeno JM, et al.
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Oct 1.
Abstract | Full Citation | | Yuan J, Lv H, Peng B, et al.
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Sep 27.
Abstract | Full Citation | Find Related Articles | | Buske C, Hoster E, Dreyling M, et al.
The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG). [JOURNAL ARTICLE]
Leukemia 2008 Sep 25.
Abstract | Full Citation |   |
|
| |
Advertise on this site.
|
